Risk of overanticoagulation during acute kidney injury in patients treated with vitamin K antagonists

BACKGROUND: Vitamin K antagonists (VKAs) are still in use for oral anticoagulation, but not all indications allow their replacement by direct oral anticoagulants. Although formal dose reduction is not required in patients with impaired kidney function, case reports indicate that acute kidney injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Süfling, Luisa, Greinert, Daniel, Girndt, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951229/
https://www.ncbi.nlm.nih.gov/pubmed/33459792
http://dx.doi.org/10.1093/ndt/gfab008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951229/
https://www.ncbi.nlm.nih.gov/pubmed/33459792
http://dx.doi.org/10.1093/ndt/gfab008

Ejemplares similares